Site-directed mutagenesis was used to identify key amino acid residues of the cholesterol oxidase from Streptomyces sp., which catalyzes the oxidation of cholesterol and the isomerization of 5-cholesten-3-one. Eight mutant enzymes were constructed and the following amino acid substitutions were identified: N318A, N318H, E356A, E356D, H441A, H441N, N480A and N480Q. Mutants N318A and N318H retained both oxidation and isomerization activities. The mutant E356D retained oxidation but not isomerization activity. On the other hand, mutants N480A and N480Q showed no oxidation activity but retained their isomerization activities. The two catalytic reactions, oxidation and isomerization, in cholesterol oxidase were thus successfully separated. When the H441A or H441N mutation was introduced, both the oxidase and isomerase activities were completely lost. The H441, E356 and N480 residues thus appear to participate in the catalysis of cholesterol oxidase, whereas N318 does not. An analysis of the products of these mutant enzymes suggested that the previously proposed 6-hydroxylation reaction by cholesterol oxidase is actually autooxidation from 5-cholesten-3-one. Kinetic studies of the purified wild-type and mutant enzymes showed that the k cat /K m values for oxidation in E356D and for isomerization in N480A increased six-and threefold, respectively, over those in the wild-type. These mutational effects and the reaction mechanisms are discussed in terms of the three-dimensional structure of the enzyme constructed on the basis of homology modeling.
Introduction
Cholesterol oxidase (3β-hydroxysteroid oxidase, EC 1.1.3.6) is a FAD-dependent bifunctional enzyme that catalyzes both the oxidation of cholesterol (5-cholesten-3β-ol) to the temporary intermediate 5-cholesten-3-one with the reduction of molecular oxygen to hydrogen peroxide and the isomerization of the steroid with a trans A:B ring junction to reduce 4-cholesten-3-one (Stadtman et al., 1954) (Figure 1 ). Bacterial cholesterol oxidases also exhibited ketosteroid monooxygenase activity which catalyzes the hydroxylation of cholesterol to 4-cholesten-6-ol-3-one (Molnár et al., 1993) . This enzyme is industrially important and is commonly used for the enzymatic transformation of cholesterol (Arima et al, 1969) . It is also useful for the clinical determination of total or free serum cholesterol by coupling with a related enzyme for the assessment of arteriosclerosis and other lipid disorders and of the risk of thrombosis (Allain et al., 1974) . Another use of the enzyme is in the microanalysis of steroids in food specimens for determining the steric configuration of 3-ketosteroids from their corresponding 3β-hydroxysteroids.
We previously cloned and sequenced the gene for cholesterol oxidase (choA) from Streptomyces sp. SA-COO (Murooka et al., 1986; Ishizaki et al., 1989) . The secretory overproduction of Streptomyces cholesterol oxidase (ChoA S ) in a Streptomyces host-vector system was demonstrated (Molnár et al., 1991) . Recently, the expression of the choA gene in Escherichia coli by genetic modification was also reported (Nomura et al., 1995) . The crystal structure of cholesterol oxidase (ChoA B ) from Brevibacterium sterolicum was determined and refined at 1.8 Å resolution, which provided a complete structural description of the enzyme (Vrielink et al., 1991) . Li et al. (1993) reported the structure of a complex of cholesterol oxidase with the steroid substrate dehydroisoandrosterone (AND), refined at 1.8 Å resolution. The steroid is buried within the protein in an internal cavity which, in the free enzyme crystal structure, is occupied by a lattice of water molecules. The hydroxyl group of the steroid substrate is hydrogen-bonded to both the flavin ring system of the FAD cofactor and a bound water molecule. The overall topology of this domain is very similar to that of other FAD-binding proteins. The amino acid sequence of ChoA S is homologous with that of ChoA B (59.2% identity; Ohta et al., 1991) . In particular, residues composing the steroid-and FAD-binding sites are highly conserved between ChoA S and ChoA B (Fujii et al., 1994) . The three-dimensional structure of ChoA S was modeled on the basis of its homology to ChoA B , whose coordinates (1COY) were obtained from the Protein Data Bank (Bernstein et al., 1997) and which provides a reasonable point for analyzing the structure-activity relationships of thermostable mutants of ChoA S created by random mutagenesis (Nishiya et al., 1997) .
To assess the role of amino acid residues in catalysis, the following mutants were prepared using the gene for cholesterol oxidase from Streptomyces sp. SA-COO: Asn318 to Ala and His, Glu356 to Ala and Asp, His441 to Ala and Asn and Asn480 to Ala and Gln. These residues were selected because they are predicted to play an important role in the active site from X-ray structural analysis of ChoA B and the structural model of ChoA S . Using these mutants, we succeeded in discriminating the two catalytic reactions of cholesterol oxidase by means of site-directed mutagenesis.
Materials and methods

Reagents and enzymes
The following steroids were used as substrates or chromatographic standards: cholesterol, 4-cholesten-3-one, 5-cholesten-3-one (Nakalai Tesque, Kyoto, Japan) and 4-cholesten-6β-ol- 3-one (Sigma Chemical, St Louis, MO, USA). Enzymes for DNA manipulation were purchased from Toyobo (Osaka, Japan), Takara Shuzo (Kyoto, Japan) or Boehringer Manheim (Mannheim, Germany) and used as described in the manufacturers' instructions. Strains, plasmids and culture conditions Escherichia coli JM109 was used as the host for recombinant DNA manipulations and for the production of wild-type and mutant cholesterol oxidases. E.coli BMH71-18, MV1184 and JM109 were used for site-directed mutagenesis. Plasmid pCO117 (Nomura et al., 1995) containing the choA gene and phage vector replicative form DNA of M13tv19 (Takara Shuzo) were used for additional plasmid construction and site-directed mutagenesis, respectively. Recombinant strains were grown in LB broth or on LB agar (Sambrook et al., 1989) . The antibiotic used was ampicillin (100 µg/ml). Manipulation and analysis of DNA DNA purification, restriction enzyme digestion, ligation, agarose gel electrophoresis and transformation of competent E.coli cells were performed according to the procedures in Sambrook et al. (1989) . The nucleotides were sequenced on an ALF DNA sequencer (Pharmacia LKB Biotechnology, Uppsala, Sweden).
Site-directed mutagenesis and construction of expression plasmids encoding mutant cholesterol oxidases
The Streptomyces cholesterol oxidase gene was subcloned from pCO117 into phage M13tv19 using the BamHI and HindIII sites. Site-directed mutagenesis was performed with a MutanG kit (Takara Shuzo) designed for the procedure of Kramer et al. (1984) according to the manufacturer's instructions. The presence of the desired mutations and absence of adventitious base changes were verified by DNA sequencing. The following oligonucleotides were used: 5Ј-GGGCTGG-GGTCCCAACGGCGCCATCATGAC-3Ј (N318A), 5Ј-GGG-CTGGGGTCCCAACGGCCACATCATGAC-3Ј (N318H), 5Ј-CGGTCTTCGCGGCGATCGCCCCCAT-3Ј (E356A), 5Ј-CG-GTCTTCGCGGATATCGCCCCCAT-3Ј (E356D), 5Ј-GACT-TCTGCTACGCCCCGCTCGGCG-3Ј (H441A), 5Ј-ACTTCT-GCTACAACCCGCTCGGCGG-3Ј (H441N), 5Ј-TCCGTCG-GCGTCGCCCCGTTCGTGA-3Ј (N480A) and 5Ј-TCCGT-CGGCGTCCAACCGTTCGTGA-3Ј (N480Q). Mutated DNA was isolated as the double-stranded replicative form from M13tv19 and digested with MluI and HindIII. A MluI-HindIII fragment (about 0.7 kb) of mutated DNA was reintroduced into the MluI and HindIII sites of plasmid pCO117 for expression of the mutant enzymes (Normura et al., 1995) .
Expression and purification of recombinant wild-type and mutant cholesterol oxidases
For the production of cholesterol oxidases, E.coli JM109 cells carrying each expression plasmid that included a wild-type or mutated choA gene were cultured in LB medium supplemented with ampicillin (100 µg/ml) and isopropyl-β-D-thiogalactopyranoside (IPTG) (final concentration 0.1 mM) at 37°C for 15 h. Recombinant wild-type and mutant cholesterol oxidases were expressed and purified according to the procedure described previously (Nomura et al., 1995) with the following modifications. The cultured cells were washed with 10 mM phosphate buffer (pH 7.0) and suspended in the same buffer. The cells were then disrupted by sonication. After centrifugation, the resulting supernatant was used as a crude enzyme for measuring cholesterol oxidase, isomerase activity and the degradation of cholesterol or 5-cholesten-3-one. All wild-type and mutant ChoA preparations were precipitated between 35 and 65% saturation of ammonium sulfate and purified by diethylaminoethyl (DEAE)-Toyopearl column exchange chromatography, gel filtration chromatography and hydrophobic chromatography to homogeneity. The protein concentration was calculated from the UV absorbances of the samples at 280 nm; precise measurements of the protein concentrations were obtained by the method of Lowry et al. (1951) using bovine serum albumin as a standard. The purity of the enzyme was assessed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using a gel containing 10% (w/v) acrylamide by the method of Laemmli (1970) and staining with Coomassie Brilliant Blue R-250. Five peptides were used as molecular weight standards: phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa) and soybean trypsin inhibitor (20.1 kDa) (Pharmacia).
In vitro steroid transformations and HPLC analysis
Cholesterol (300 mM) and 5-cholesten-3-one (300 mM) were transformed in in vitro reactions by appropriate dilution of cell extracts in reaction mixtures (1.2 ml) containing 10 mM phosphate buffer (pH 7.0) and overnight incubation at 37°C with glacial acetic acid (Molnár et al., 1993) . After the reactions mixtures had been extracted three times with ethyl acetate, the organic phases were pooled and the solvent was evaporated at 60°C under a flow of nitrogen. The dried extract was dissolved in 40 µl of ethyl acetate and steroid extracts (5 µl) were analyzed by reversed-phase high-performance liquid chromatography (HPLC) (Model 88-PU chromatograph; Japan Spectroscopic, Tokyo, Japan) with an ODS-2 column (250ϫ4.6 mm i.d., pore size 5.6 mm; GL Science, Tokyo, Japan). The mobile phase was 100% acetonitrile and the flow-rate was maintained at 1.0 ml/min throughout. Steroid metabolites eluting from the column were monitored with a Model 870-UV UV-visible detector (Japan Spectroscopic) set at 212 nm. Enzyme assay Cholesterol oxidation and isomerization activities were determined by the methods of Allain et al. (1974) and Keesey (1987) , respectively. Enzyme solutions (0.5-1.0 U/ml) were prepared by dilution with 10 mM phosphate buffer (pH 7.0). To determine cholesterol oxidase activity, the appearance of quinoneimine dye formed by coupling with 4-aminoantipyrine, phenol and peroxidase was measured at 500 nm by spectrophometry. One unit of activity was defined as the formation of 1 µmol of hydrogen peroxide (0.5 µmol of quinoneimine dye) per minute at 37°C and pH 7.0. 4-Cholesten-3-one, which is the product of cholesterol isomerase from 5-cholesten-3-one, was measured at 240 nm by spectrophotometry. One unit of activity was defined as the formation of 1 -µmol of 4-cholesten-3-one per minute at 37°C and pH 7.0. Kinetic studies When the progress curve for an enzyme-catalyzed reaction follows the integrated Michaelis-Menten equation, the maximum velocity and Michaelis constant can be determined from a single experiment. This type of data processing is possible for stable enzymes catalyzing an irreversible reaction with a single substrate and for which none of the reaction products is inhibitory. A reaction mixture consisting of 0-1.0 mM substrate solution was used to calculate the K m and k cat values. The kinetic data were analyzed by double reciprocal plots.
Results
Three-dimensional structure and predicted amino acid residues involved in the active center of ChoA S In the three-dimensional model of ChoA S (Nishiya et al.,1997) , FAD and the steroid substrate dehydroisoandrosterone (AND) were placed at the corresponding sites in ChoA B . (Li et al., 1993) . A single water molecule (hereafter designated W541) was also placed in the active-site cavity of the model. W541 binds AND and FAD. Li et al. (1993) suggested that the water molecule plays an important role in the catalytic reaction of cholesterol oxidase. When we searched the ChoA S structure for conserved amino acid residues surrounding the water molecule, the side-chains of Asn480 and His441 were found to be located within hydrogen-bonding distance of the water molecule (Figure 2 ). Glu356 can interact with His441 via the water molecule. Asn480 also participates in the extensive hydrogen-bonding network around the water molecule. The side-chain of residue Asn318 forms a hydrogen bond with the imidazole ring of His441. The relative disposition of the amino acid residues, AND and FAD near W541 is depicted schematically in Figure 5 . To analyze the functions of each of the amino acids around W541, we individually mutated amino acid residues Glu356, His441, Asn480 and Asn318.
Construction and activities of mutant derivatives of ChoA
The eight newly constructed mutant genes of cholesterol oxidase were confirmed to code for N318A, N318H, E356A, E356D, H441A, H441N, N480A and N480Q by their nucleo- tide sequences. Only the desired changes were found in the coding sequences. The productivities of these mutant enzymes and their activities for the oxidation and isomerization reactions were analyzed in crude extracts of E.coli cells carrying the plasmid with each gene. The oxidase activities of the mutants E356A, H441A, H441N, N480A and N480Q decreased~200-fold compared with that of the wild-type enzyme (Table I) . The crude enzymes of the two His441 mutants showed no oxidase activity even when concentrated 100-fold. The mutants N318A, N318H and E356D retained their oxidation activities.
No isomerase activity was found in mutants E356A, E356D, H441A or H441N, whereas N480A and N480Q retained about 27 and 44% of the isomerization activity of the wild-type, respectively. The mutations of the Asn318 residue also retained their isomerization activities. The productivities of the mutant enzymes in E.coli were assessed using anti-cholesterol oxidase. The level of E356A protein in the crude extract was 10-fold lower than the levels in the wild-type and E356D mutant enzymes. The other mutant enzymes showed similar productivities to that of the wild-type (data not shown). Glu356 mutations thus remove the isomerization activity but not the oxidation activity; in E356D the oxidation activity was enhanced. In contrast, the Asn480 residue is involved in the oxidation reaction but not in isomerization. The mutations of the His441 residue showed no activity for either oxidation or isomerization. Thus, the His441 residue seems to take part in the catalysis of cholesterol oxidase, but the Asn318 residue does not.
Detection of biodegradation products from cholesterol
To detect the cholesterol biodegradation products arising as a consequence of the expression of the wild-type and mutant choA genes, cholesterol or 5-cholesten-3-one was incubated with the wild-type and mutant enzymes and the reaction mixtures were analyzed by HPLC.
As shown previously (Molnár et al. 1993 ), a small amount of 4-cholesten-3-one (peak 2 in Figure 3 ) was formed by autooxidation from cholesterol (peak 1) without any enzyme. 4-Cholesten-3-one was formed significantly in reaction mixtures containing cholesterol and the wild-type or mutant enzymes of N480A and N480Q, but only very slightly or not at all with E356A, E356D, H441A or H441N. The fact that the E356A and E356D enzymes were found to have oxidase but not isomerase activity (Table I) is consistent with the finding that the E356D mutant enzyme degraded cholesterol and formed 5-cholesten-3-one (peak 3) as a main product. The E356D mutant enzyme also formed 4-cholesten-6b-ol-3-one (peak 4) and some unknown products. In the E356A enzyme, 5-cholesten-3-one was also detected, although most of the substrate, cholesterol, was left without degradation. E356A thus has a little oxidase activity but no activity for isomerase. The N480A and N480Q enzymes formed 4-cholesten-3-one, although most of the cholesterol was left without degradation. The two Asn480 mutants seemed to display only very faint oxidase activity before immediately forming 4-cholesten-3-one by isomerization.
The mutant enzymes were further characterized in a similar manner with 5-cholesten-3-one as the substrate. In this case, the authentic 5-cholesten-3-one (peak 3) was found to be unstable and to contain 4-cholesten-3-one (peak 2), 4-cholesten-6β-ol-3-one (peak 4) and unknown minor products (Figure 4) . 5-Cholesten-3-one was degraded and formed 4-cholesten-3-one when extracts from E.coli pCO117 containing the wild-type or Asn480 mutant enzymes were employed. However, 5-cholesten-3-one remained intact when E356A, E356D, H441A or H441N was employed, supporting the finding that these mutant enzymes have no isomerase activity. We previously reported that bacterial cholesterol oxidases also exhibited ketosteroid monooxygenase activity that catalyzed the hydroxylation of cholesterol to 4-cholesten-6-ol-3-one and postulated that it may be produced via 5-cholesten-3-one (Molnár et al., 1993) . However, all the data for the wild-type and mutant enzymes in the present study suggest that 4-cholesten-6β-ol-3-one (peak 4) was formed only when 5-cholesten-3-one (peak 3) was accumulated. In N480A or N480Q, 5-cholesten-3-one was immediately catalyzed to 4-cholesten-3-one by isomerization without the formation of 4-cholesten-6β-ol-3-one. These results suggest that 4-cholesten-6-ol-3-one is autooxidized from 5-cholesten-3-one without any enzyme.
Kinetic properties of mutant enzymes
To determine kinetic parameters of the oxidation and isomerization catalytic activities, the N318A, N318H, E356D, N480A and N480Q mutant enzymes were overexpressed in E.coli JM109 and purified to homogeneity. On SDS-PAGE, each of these purified enzymes showed a single band and the same mobility as that of the wild type. The k cat and K m values of the five purified mutant enzymes were then compared with those of the wild-type enzyme purified from E.coli (pCO117) cells (Table II) . The oxidation of catalytic efficiency (k cat /K m ) of N318A or N318H decreased 27-and 287-fold, respectively, whereas E356D increased sixfold over that of the wild-type enzyme (Table II) . The improvement of E356D in the catalytic activity of oxidation resulted from the lower K m value and the higher k cat value (which increased by a factor of about 3.5). The K m values for 5-cholesten-3-one in the N318H, N480A and N480Q enzymes were 0.12-, 0.68-and 0.27-fold lower, respectively, and the catalytic efficiencies (k cat /K m ) in the isomerization of N480A and N480Q were 3.0-and 1.7-fold higher, respectively, than those of the wild-type enzyme. The catalytic efficiencies in the isomerization of N318A and N318H were 0.12-and 0.20-fold lower, respectively, than that of the wild-type enzyme. The improvement of isomerase activity in N480A was a result of the higher k cat value. These results suggest that Glu356 takes part in the transfer of the 4β-proton of the steroid in the rate-limiting step and that Asn480 in the catalytic site does not participate directly in substrate binding with the transfer of hydrogen. a Cholesterol and 5-cholesten-3-one were used as the substrate for assays of oxidation and isomerization reactions, respectively. The purified wild-type and mutant enzymes at concentrations of 0.1 mg/ml were used.
Discussion
We succeeded in identifying several structurally important residues for the catalytic reactions of cholesterol oxidase from Streptomyces produced in E.coli. To assess the functions of the individual amino acids, we analyzed the three-dimensional structure of ChoA S constructed by homology modeling (Nishiya et al.,1997) . The three-dimensional structures of ChoA S and ChoA B together with the site-directed mutagenesis of ChoA S enabled us to obtain a deeper understanding of the reaction mechanisms of the enzyme. The three-dimensional arrangement of the several specific amino acids, AND, FAD and W541 in the cavity of the active site should be responsible for oxidation. In the catalytic mechanism, W541 plays a key role in conjunction with His441. His441 should control the reactivity of W541 and the tautomeric form of the imidazole ring of His441 appears to be particularly crucial in controlling the reactivity of W541. Thus, substitution of His422 by other amino acids resulted in the complete loss of enzyme activity. The δ-nitrogen of Asn318 is within hydrogen-bonding distance of the δ-nitrogen of His441. The imidazole ring of N318H is too bulky to be occluded in the space between residues 318 and 441 and the resultant steric hindrance may destroy the proper structure of the active site. The decrease in the oxidation reactivity of N318H may be due to this steric effect.
W541 is engaged in at least three hydrogen bonds and these bonds cooperatively determine the optimal position of W541 favorable for the reaction. Asn480 is hydrogen-bonded to W541 and holds W541. W541, however, cannot be tethered to N480A. The side-chain of N480Q is too bulky to be accommodated in the active site. Therefore, these two mutants show no detectable oxidation activity. Li et al. (1993) suggested that distances between the carboxyl oxygen atoms of Glu356 and W541 are relatively long and Glu356 is unlikely to be involved in the oxidation reaction. However, Sampson and Kass (1997) reported that the oxidation activity of E356Q decreased significantly and Glu356 should be important for the reaction. The oxidation activities of E356D shown in Table I suggest that the carboxyl group is essential for the oxidation and support the observations of Sampson and Kass (1997) . These results indicate that electrostatic interactions between the carboxyl group and the hydroxyl group at the 3-position of the substrate could promote the oxidation reaction in conjunction with W541 ( Figure 5 ). On the other hand the carboxyl group of Glu356 is located near W541. Hence Glu356 could compete with His441 for accepting a proton from W541 and significantly affect the dissociation of W541. Since the side-chain of E356D is shorter than that of Glu356, E356D could not interfere with the function of W541. The marked enhancement of the oxidation activity of E356D is likely to be due to this reason.
The isomerization step of cholesterol oxidase seems to be identical with that of the enzyme ∆ 5 -3-ketosteroid isomerase from Pseudomonas testosterone suggested by Smith and Brooks (1977) and Li et al. (1993) . The mechanism of isomerization adopted by ∆ 5 -3-ketoisomerase involves the intramolecular, cis-diaxial transfer of the 4β-proton to the 6β-position by way of an enolic intermediate, as reported by Sampson and Kass (1997) . In this reaction, an enolate ion would be formed and the resulting proton could act as an acid, allowing an electrophilic attack on the conjugated diene and finally the formation of 4-cholesten-3-one. According to this mechanism, Glu356 could act as the base which abstracts the axial hydrogen at C-4 of the steroid (Figure 6 ).
W541 is important in stabilizing the enolate ion. His441 must hold W541 at a position suitable for the stabilization. Thus, substituting His441 by Ala or Asn resulted in the complete loss of isomerization activity. Oxidation of the steroid to 5-cholesten-3-one causes the steroid ring to change its pucker such that the distance between the C-4 position and the carboxyl side-chain of E356 may be short, favorable for isomerization. To tether W541 which is essential for isomerization, the imidazole ring of His441 must adopt an appropriate tautomer and Asn318 is responsible for it.
The 4,6-diaxial proton plays an important role during the isomerization step (Sampson and Kass, 1997) . The positive charge on C-5 of 5-cholesten-3-one would have to be neutralized by acidic residues. Glu356 should be responsible for this role. Although E356D possesses a carboxyl group, it cannot stabilize the carbocation owing to the short side-chain. E356A does not have a carboxyl group. Therefore, the E356D and E356A mutants result in the complete loss of isomerization activity.
Asn480 is hydrogen-bonded to W541 and W541 plays a key role in both oxidation and isomerization. After oxidation, the position of W541 will possibly shift to orient hydrogen atoms favorable for isomerization. Therefore, the residue 480 might affect the isomerization. Substitutions of Asn480 to Ala and Gln cause complete loss of oxidation activity. The mutants, however, retain isomerization activity, as shown in Table II . The side-chain of N480Q is so bulky that W541 will be significantly shifted from the proper position for isomerization, which may be favorable for binding the substrate but be unfavorable for the reaction. The smaller K m and K cat values of N480Q than those of the wild-type may be due to this reason. The significant increase in K cat for N480A indicates that tethering W541 by this residue is unfavorable for isomerization and W541 should shift appreciably during isomerization. On the other hand, the decrease in K m indicates that the movement of W541 in the N480A mutant could make more space for the substrate binding.
Site-direct mutagenesis has clarified that the two reactions, oxidation and isomerization, of cholesterol oxidase occur via the water molecule and that the His441 residue is an essential amino acid residue for both of them. For the two reactions to proceed efficiently, Asn318, Glu356 and Asn480 must function cooperatively. We have succeeded in creating new enzymes that catalyze either the oxidation of cholesterol or the isomerization of 5-cholesten-3-one, as well as in enzyme improvement with respect to either or both reaction rates by the substitution of some amino acids. These findings will provide useful ideas for the design of more powerful enzymes.
